Health Condition 1: L669- Cicatricial alopecia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Both genders with age group 18-50 years 2. H/O diffuse hair loss
Exclusion criteria
Exclusion criteria: 1. Patients below 18 years and above 50 years. 2. Known cases of cardiovascular diseases, renal diseases and liver diseases. 3. Known case of malignancy 4. Patients on immunosuppressive drugs. 5. Patient who fails to follow up. 6. Patients applying other topical therapy for diffuse hair loss in last 2 weeks. 7. Patients with evidence of skin infection. 8. Pregnancy and lactating mothers.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and at the end of treatment i.e. 3months | — |
Primary
| Measure | Time frame |
|---|---|
| The therapeutic efficacy will be assessed on the basis of Trichoscopy, Hair Shedding visual Scale, Pull test and Photographic assessmentTimepoint: At every 4 weeks for 3 months | — |
Countries
India
Contacts
Central Council for Research in Unani Medicine (CCRUM)